Comparison Between Platelet Rich Plasma and Nanofat as an Adjuvant Therapy in HairTransplantation
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
- To compare the efficacy of platlet rich plasma and Nanofat injection as adjuvant therapies with FUE hair transplantation in improving graft survival rate,
- To measure hair density and thickness postoperatively using dermoscopy or trichoscopy.
- To evaluate patient satisfaction and photographic assessment by blinded evaluators.
- To assess any adverse effects or complications related to each modality
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2025
CompletedFirst Posted
Study publicly available on registry
December 17, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
December 17, 2025
November 1, 2025
1.4 years
November 22, 2025
December 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
• To measure hair density using dermoscopy.
To measure how many hair follicles in each cubic centimetre
• All patients will be followed up about 6-12 months postoperative.
Study Arms (3)
group a
EXPERIMENTALhair transplantation done alone without platelet rich plasma or nanofat injection
group b
EXPERIMENTALwe do injection of platelet rich plasma with hair transplantation
group c
EXPERIMENTALwe do injection of nanofat with hair transplantation
Interventions
we compare the effect of nanofat injection and platelet rich plasma in hair transplantation in male androgenic alopecia
Eligibility Criteria
You may qualify if:
- \. Male patients with stable androgenic alopecia more than 2 years. 2. Age 20-50 years 3. No recent medical hair loss treatments.
You may not qualify if:
- \. Active scalp infections or scarring alopecia. 2. Systemic diseases affecting wound healing. 3. Platelet disorders or anticoagulant use. 4. Smoking or heavy alcohol intake
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Related Publications (1)
Evin N, Guray Evin S. Camouflage of Postburn Scarring Alopecia Using Nanofat Grafting and Follicular Unit Hair Transplantation. Plast Reconstr Surg. 2024 Jul 1;154(1):207-215. doi: 10.1097/PRS.0000000000010759. Epub 2023 May 26.
PMID: 37253046BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
samia saied, MD
Sohag University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer in plastic surgery department, faculty of medicine Sohag University hospital.
Study Record Dates
First Submitted
November 22, 2025
First Posted
December 17, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
December 17, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share